This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation
Friday, April 9, 2021
Source Name: The Annals of Thoracic Surgery
This investigation studied the effectiveness of methylene blue (MB) for vasoplegia in LVAD recipients and found that clinical outcomes did not improve after LVAD implantation.